The actions of the Drug Enforcement Agency (DEA) have caused another delay in marijuana rescheduling – hurting thousands of mom and pop businesses.
While thousands of mom and pop business’s future hangs in the balance, the DEA causes another delay in marijuana rescheduling. Â Ever since outgoing President Biden delayed starting the process, the Drug Enforcement Administration (DEA) has been dragging their feet on any action. And now they have been ordered to delay to do some questionable actions. While the majority of the public believe it should be legalized and consumer usage has increased, even starting the California sober trend. The DEA and a few members of Congress have fought hard and long against science and public opinion.
RELATED: Marijuana Users Gain Less Weight Than Non-Users
The rescheduling process has been complicated by the DEA’s action, including a lack of clarity regarding participants in the hearing for proposed rule change. These complications have led some observers to express skepticism about the likelihood of successful rescheduling in light of recent political developments and the DEA resistance and administrative hurdles.
Despite these setbacks, there is still momentum behind the push to reschedule marijuana. The U.S. Department of Health and Human Services (HHS) has previously concluded that cannabis does not meet the criteria for a Schedule I drug, citing credible scientific support for its medical use. The Food and Drug Administration concurred with the recommendation. This conclusion aligns with growing public sentiment favoring cannabis legalization and reform of its federal status.
As advocates and industry businesses continue to navigate this complex landscape, they remain hopeful ongoing discussions and potential legal challenges will ultimately lead to a more favorable outcome for cannabis rescheduling. The upcoming months will be critical as stakeholders await further developments in this evolving regulatory environment.
